MAGNESIUM SULFATE INJECTION, BP 49.3%
Google image searchProduct monograph
Active ingredient
magnesium sulfate, 493 MG/ML
DIN: 02513161
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: BAXTER CORPORATION
Date: 01-OCT-2021
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05X — I.V. SOLUTION ADDITIVES (ATC, ATC/DDD)
- B05XA — Electrolyte solutions (ATC, ATC/DDD)
- B05XA05 — MAGNESIUM SULPHATE (ATC/DDD)
Pharmaceutical standard: BP
